Member access

4-Traders Homepage  >  Shares  >  Amex  >  ImmunoCellular Therapeutics Ltd    IMUC   US4525361055

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Amex
09/15/2014 09/16/2014 09/17/2014 09/18/2014 09/19/2014 Date
0.9198(c) 0.89(c) 0.97(c) 0.9206(c) 1(c) Last
247 152 295 491 1 596 795 475 709 579 884 Volume
-0.98% -3.24% +8.99% -5.09% +8.62% Change
More quotes
Company
ImmunoCellular Therapeutics Ltd. is a clinical-stage biotechnology company, which focuses on developing immune-based therapies for the treatment of brain and other cancers.Its cell-based vaccine technologies are primary platform technologies and commercial prospects will be heavily dependent on the... 
More about the company
Chart IMMUNOCELLULAR THERAPEUTIC
Duration : Period :
ImmunoCellular Therapeutic Technical Analysis Chart | IMUC | US4525361055 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 -
EBIT 2014 -11,3 M
Net income 2014 -12,8 M
Debt 2014 -
Yield 2014 -
Sales 2015 -
EBIT 2015 -16,4 M
Net income 2015 -16,3 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 0
Capitalization 55,8 M
More Financials
Latest news on IMMUNOCELLULAR THERAPEUTIC
3d ago IMMUNOCELLULAR THERAPEUTICS : Other Events, Financial Statements and Exhibits (f..
3d ago IMMUNOCELLULAR THERAPEUTICS : Receives Positive Regulatory Feedback on ICT-107 S..
09/02 IMMUNOCELLULAR THERAPEUTICS : Change in Directors or Principal Officers (form 8-..
08/16 IMMUNOCELLULAR THERAPEUTICS : Reports 2Q Financial Results
08/12 IMMUNOCELLULAR THERAPEUTICS : Posts 2Q Financial Results
08/08 IMMUNOCELLULAR THERAPEUTICS : Management's Discussion and Analysis of Financial ..
08/07 IMMUNOCELLULAR THERAPEUTICS : Results of Operations and Financial Condition, Fin..
08/07 IMMUNOCELLULAR THERAPEUTICS : Announces Second Quarter 2014 Financial Results
07/29 IMMUNOCELLULAR THERAPEUTICS : to Report Financial Results for the Second Quarter..
07/16 WEDNESDAY SECTOR LAGGARDS : Drugs, Biotechnology Stocks
06/19 IMMUNOCELLULAR THERAPEUTICS : Submission of Matters to a Vote of Security Holder..
06/11 IMMUNOCELLULAR THERAPEUTICS : Presents Updated ICT-107 Phase II Data in Patients..
More news
Comments 
Advertisement
Income Statement Evolution
ImmunoCellular Therapeutic : Income Statement Evolution
More Financials
EPS Revisions
ImmunoCellular Therapeutic : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF